Pharmell Life Sciences offers free access to high-potential early-stage Life Sciences companies—sourced worldwide across Biotech, Medtech, Healthtech and Pharma, reducing your scouting efforts—while also connecting you with like-minded investors.
Investing in Life Sciences companies through Pharmell Life Sciences is simple.
Pharmell Life Sciences is reshaping the Life Sciences investment landscape by making it easier to find top opportunities, connect with aligned investors, and boost returns.
Discover the opportunities
Register or sign in to the platform to gain access to exclusive investment opportunities
Our Life Sciences focus, backed by top-tier due diligence partners trusted by VCs, ensures investors access thoroughly vetted, high-integrity opportunities.
Our platform goes beyond deal discovery—by connecting investors who share similar objectives. Whether it’s a specific therapeutic area, funding stage, or geographic focus, we help you co-invest with aligned peers to build stronger syndicates and amplify impact.
We offer free access to exclusive investment opportunities with no investment fees. If you decide to invest, a low disruptive 3% success fee is charged to the company.
Advantages for Investors
Gain access to vetted, high-potential early-stage Life Sciences companies. As an investor, you can also propose your own promising start-ups for inclusion on the platform. Once approved through our independent due diligence process, these companies become visible to our investor network—unlocking co-investment opportunities, capital, and strategic support from peers who bring not just funding, but valuable industry expertise.
Advantages for Companies
Promising early-stage Life Sciences companies gain global visibility to a curated network of investors, benefit from a streamlined fundraising process, hands-on support with investor interactions, and a disruptive success fee of only 3%—maximizing capital efficiency while accelerating growth.